Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 25, 2015 11:49 PM ET


Company Overview of Indel Therapeutics Inc

Executive Profile

Michael J. Abrams Ph.D.

Chief Discovery Officer and Executive Vice President, Tekmira Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships


Dr. Michael J. Abrams, also known as Mike, Ph.D., has been the Chief Discovery Officer and Executive Vice President of Tekmira Pharmaceuticals Corporation since January 6, 2014. Dr. Abrams serves as Corporate Secretary of Spartan Bioscience, Inc. He serves as Scientific Advisor of Tarix Pharmaceuticals LTD. Dr. Abrams has been the Chief Executive Officer and President at Inimex Pharmaceuticals Inc. since November 24, 2009. He was a Co-founder of AnorMED Inc. and served ...

Corporate Headquarters

4068 West 11th Avenue
Vancouver, British Columbia V6R 2L3


Phone: 604-551-8464
Fax: 604-909-1811

Board Members Memberships

Chief Executive Officer, President and Director
Executive Chairman
Former Chief Executive Officer, President and Director
Former Director, Member of Special Committee and Member of Compensation Committee
Chief Discovery Officer and Executive Vice President


BA 1978
Bowdoin College
PhD 1983
Massachusetts Institute of Technology
Unknown/Other Education
University Of Ottawa

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$41,250
Total Calculated Compensation$41,250

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
J. Michael French Chairman, Chief Executive Officer and President
Marina Biotech, Inc.
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Indel Therapeutics Inc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at